Skip to content
Inciteful Med

Standard of Care & Daily Management

Last updated:

Managing Ehlers-Danlos Syndrome (EDS) requires a multidisciplinary approach focused on protecting fragile joints and managing chronic pain. Safe physical therapy utilizing isometric exercises, along with joint braces and mobility aids, form the core of daily treatment and symptom management.

Key Takeaways

  • • Physical therapy for EDS should focus on isometric exercises and joint position awareness rather than traditional stretching.
  • • Braces, splints, and mobility aids are essential tools for protecting unstable joints and managing daily fatigue.
  • • Vascular EDS requires strict medical monitoring, emergency preparedness, and specific blood pressure medications to prevent arterial ruptures.
  • • Surgery carries significantly higher risks for EDS patients due to fragile connective tissue, vascular risks, and poor wound healing.

Managing Ehlers-Danlos Syndrome (EDS) and Hypermobility Spectrum Disorder (HSD) requires a multidisciplinary approach—a team of specialists working together to address the condition’s effects on your whole body [1][2]. Because there is no “pill” to fix collagen, the goal of treatment is to manage symptoms, protect your joints, and improve your quality of life [3][4].

The Core of Care: Physical Therapy

Physical therapy (PT) is the most critical tool for managing joint instability and chronic pain [1][5]. However, “standard” PT can sometimes be harmful if it focuses too much on stretching or pushing past your range of motion [1]. Tip: Ask your PT for a “safe range of motion” assessment before starting exercises to prevent well-meaning therapists from stretching you into subluxations.

Effective PT for EDS usually includes:

  • Isometric Exercises: Exercises where muscles contract without moving the joint, which helps build strength without causing subluxations [1].
  • Proprioception Training: Improving your “joint position sense” (knowing where your limbs are in space), which is often impaired in EDS [6][1].
  • Activity Pacing: Learning how to balance rest and movement to avoid the “boom and bust” cycle of overexertion followed by days of extreme fatigue [7][8].

Physical Supports & Daily Living

Beyond PT, patients rely heavily on physical management tools to survive everyday life safely. These joint protection tools are essential:

  • Braces and Splints: Custom or over-the-counter braces (like silver ring splints for fingers) prevent joints from hyper-extending [1].
  • Kinesiology Tape (KT Tape): Can provide sensory feedback and mild support for unstable joints [1].
  • Mobility Aids: Canes, walkers, or wheelchairs are incredibly valid tools for managing fatigue and preventing lower-body injuries on bad pain days [7].
  • Heat/Ice Therapy: Frequently used to manage acute flares and muscle spasms.

Managing Chronic Pain

Pain in EDS is complex and often stems from both joint instability and central sensitization (where the nervous system becomes “hypersensitive” to pain signals) [9][10].

  • Non-Drug Options: Cognitive Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT) can be helpful for managing the psychological toll of chronic pain and reducing fear of movement [7][11].
  • Medications: Over-the-counter anti-inflammatories (NSAIDs) or acetaminophen are common first steps [12]. For widespread pain, doctors may consider SNRIs [12]. Opioids are generally not recommended as a first-line treatment for chronic pain due to the risk of tolerance and hyperalgesia, but they are sometimes relied upon safely for acute injuries, severe dislocations, or post-surgical care when other medications fail [12][13].

Specialized Care for Vascular EDS (vEDS)

Patients with the COL3A1 mutation (vEDS) require more intensive medical monitoring due to the risk of internal organ or blood vessel rupture [14][15].

  • Emergency Preparedness: Because vEDS carries the risk of sudden arterial dissection or hollow organ rupture, patients must wear a medical alert bracelet and carry an emergency letter. Any sudden, severe, or unexplained pain (especially in the chest, abdomen, or head) requires immediate evaluation in the ER [15][16].
  • Surveillance: Regular imaging (like MRA or CTA scans) is essential to monitor the health of your arteries, even if you feel fine [15][17].
  • Medication: Celiprolol is the standard evidence-based treatment used to reduce the risk of major vascular events [18][14]. Recent studies also suggest that adding an ARB (like irbesartan) may provide additional protection [19][15].

A Note on Surgery

Surgery in the EDS population is approached with extreme caution [20][21]. Because connective tissue is fragile, EDS patients face higher risks of:

  • Poor Wound Healing: Incisions may pull apart or heal with very thin, wide scars [20][22].
  • Tissue Fragility: Stitches may “cheese-wire” (tear through) the delicate tissue [20].
  • Vascular Risks: Increased risk of bleeding or, in the case of vEDS, life-threatening arterial rupture during the procedure [23][24].

Elective surgeries should only be considered after a thorough discussion of the risks and should ideally be performed by surgeons familiar with EDS [21][23].

Frequently Asked Questions

What type of physical therapy is best for EDS?
The most effective physical therapy for EDS focuses on isometric exercises and proprioception training to build strength and joint awareness. It is crucial to avoid standard stretching that pushes joints past their safe range of motion, which can cause painful subluxations.
How is chronic pain managed in Ehlers-Danlos Syndrome?
Pain management involves a mix of physical joint supports, medications like NSAIDs or SNRIs, and therapies such as Cognitive Behavioral Therapy. Learning to pace your daily activities is also vital to avoid overexertion and reduce severe fatigue.
What are the treatment options for Vascular EDS (vEDS)?
Patients with Vascular EDS need regular imaging scans to monitor arterial health and strict emergency preparedness plans. The standard treatment includes taking celiprolol, and sometimes an ARB like irbesartan, to reduce the risk of major blood vessel complications.
Why is surgery risky for people with Ehlers-Danlos Syndrome?
Because EDS affects the structural integrity of connective tissue, patients have fragile skin and blood vessels. This leads to higher risks of poor wound healing, wide scarring, stitches tearing through tissue, and increased bleeding during procedures.

Questions for Your Doctor

  • • Are you familiar with the specific physical therapy needs of hypermobile patients, such as focusing on isometric exercises and proprioception?
  • • Can you refer me to a physical therapist who has experience with EDS/HSD patients to avoid potential injury from 'standard' stretching?
  • • If I have Vascular EDS, what is your recommended schedule for vascular imaging (MRA or CTA) for monitoring?
  • • Should we consider adding an ARB (like irbesartan) to my celiprolol therapy, based on recent research?
  • • If I need surgery or a dental procedure, how should we adjust for potential issues like local anesthetic resistance or tissue fragility?

Questions for You

  • • Which joints feel the most 'unstable' or prone to subluxations in my daily life?
  • • How does my pain change throughout the day, and does 'activity pacing' help reduce my fatigue?
  • • Have I ever had a surgery where the incision took an unusually long time to heal or the scar became very wide?
  • • What are my personal goals for physical therapy—is it reducing pain, improving stability, or returning to a specific activity?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Recognizing and Effectively Managing Hypermobility-Related Conditions.

    Russek LN, Stott P, Simmonds J

    Physical therapy 2019; (99(9)):1189-1200 doi:10.1093/ptj/pzz078.

    PMID: 31158283
  2. 2

    Hypermobile Ehlers-Danlos syndrome and disorders of the gastrointestinal tract: What the gastroenterologist needs to know.

    Thwaites PA, Gibson PR, Burgell RE

    Journal of gastroenterology and hepatology 2022; (37(9)):1693-1709 doi:10.1111/jgh.15927.

    PMID: 35750466
  3. 3

    Recurrent Depression and Borderline Personality Disorder in a Patient with Ehlers-Danlos Syndrome.

    Espiridion ED, Daniel A, Van Allen JR

    Cureus 2018; (10(12)):e3760 doi:10.7759/cureus.3760.

    PMID: 30820380
  4. 4

    Defining the Chronic Complexities of hEDS and HSD: A Global Survey of Diagnostic Challenges, Life-Long Comorbidities, and Unmet Needs.

    Daylor V, Griggs M, Weintraub A, et al.

    Journal of clinical medicine 2025; (14(16)) doi:10.3390/jcm14165636.

    PMID: 40869462
  5. 5

    Physical therapy interventions in generalized hypermobility spectrum disorder and hypermobile Ehlers-Danlos syndrome: a scoping review.

    Garreth Brittain M, Flanagan S, Foreman L, Teran-Wodzinski P

    Disability and rehabilitation 2024; (46(10)):1936-1953 doi:10.1080/09638288.2023.2216028.

    PMID: 37231592
  6. 6

    Home-based exercise therapy for treating shoulder instability in patients with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorders. A randomized trial.

    Spanhove V, De Wandele I, Malfait F, et al.

    Disability and rehabilitation 2023; (45(11)):1811-1821 doi:10.1080/09638288.2022.2076932.

    PMID: 35609204
  7. 7

    Developing a self-management intervention to manage hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS): an analysis informed by behaviour change theory.

    Bennett SE, Walsh N, Moss T, Palmer S

    Disability and rehabilitation 2022; (44(18)):5231-5240 doi:10.1080/09638288.2021.1933618.

    PMID: 34101520
  8. 8

    Fear avoidance, fear of falling, and pain disability in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.

    Chuchin JD, Ornstein TJ

    Disability and rehabilitation 2024; (46(18)):4234-4245 doi:10.1080/09638288.2023.2268520.

    PMID: 37843031
  9. 9

    Central sensitization as the mechanism underlying pain in joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type.

    Di Stefano G, Celletti C, Baron R, et al.

    European journal of pain (London, England) 2016; (20(8)):1319-25 doi:10.1002/ejp.856.

    PMID: 26919608
  10. 10

    Interdisciplinary pain rehabilitation for patients with Ehlers-Danlos syndrome and hypermobility spectrum disorders.

    Molander P, Novo M, Ringqvist Å, et al.

    Journal of rehabilitation medicine 2024; (56()):jrm12431 doi:10.2340/jrm.v56.12431.

    PMID: 38323531
  11. 11

    Psychological interventions for individuals with Ehlers-Danlos syndrome and hypermobility spectrum disorder: a scoping review.

    Song JZ, Luong D, Feldman ECH, et al.

    Orphanet journal of rare diseases 2023; (18(1)):254 doi:10.1186/s13023-023-02799-y.

    PMID: 37653505
  12. 12

    Hypermobility spectrum disorders: A review.

    Carroll MB

    Rheumatology and immunology research 2023; (4(2)):60-68 doi:10.2478/rir-2023-0010.

    PMID: 37637226
  13. 13

    Perioperative opioid-minimization approach as a useful protocol in the management of patients with Ehlers-Danlos syndrome-hypermobility type, craniocervical instability and severe chronic pain who are to undergo occipito-cervical fixation.

    Ramírez-Paesano C, Rodiera Clarens C, Sharp Segovia A, et al.

    Orphanet journal of rare diseases 2023; (18(1)):214 doi:10.1186/s13023-023-02829-9.

    PMID: 37491286
  14. 14

    Current Evidence and Future Perspectives in the Medical Management of Vascular Ehlers-Danlos Syndrome: Focus on Vascular Prevention.

    Buso G, Corvini F, Fusco EM, et al.

    Journal of clinical medicine 2024; (13(14)) doi:10.3390/jcm13144255.

    PMID: 39064294
  15. 15

    Challenges in the Management of Patients with Vascular Ehlers-Danlos Syndrome: Lessons from three Clinical Cases.

    Alayasa L, Fiala R, Skafi A, et al.

    European journal of case reports in internal medicine 2025; (12(12)):005837 doi:10.12890/2025_005837.

    PMID: 41377782
  16. 16

    Generation of the human induced pluripotent stem cell line (IBKMOLi003-A) from PBMCs of a vascular Ehlers-Danlos syndrome (vEDS) patient carrying the heterozygous nonsense mutation c.430C > T (p.Q105*) in the COL3A1 gene.

    Höpperger S, Spathopoulou A, Mayer-Suess L, et al.

    Stem cell research 2024; (75()):103321 doi:10.1016/j.scr.2024.103321.

    PMID: 38301384
  17. 17

    Arteriovenous fistula following radial artery cannulation in a patient with vascular Ehlers-Danlos syndrome.

    Gionet G, Savoie-White FH, Gegiia I, et al.

    Journal of vascular surgery cases and innovative techniques 2025; (11(4)):101822 doi:10.1016/j.jvscit.2025.101822.

    PMID: 40496663
  18. 18

    Celiprolol Treatment in Patients with Vascular Ehlers-Danlos Syndrome.

    Baderkhan H, Wanhainen A, Stenborg A, et al.

    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2021; (61(2)):326-331 doi:10.1016/j.ejvs.2020.10.020.

    PMID: 33223285
  19. 19

    Efficacy of Irbesartan in Celiprolol-Treated Patients With Vascular Ehlers-Danlos Syndrome.

    Jeunemaitre X, Mousseaux E, Frank M, et al.

    Circulation 2025; (151(10)):686-695 doi:10.1161/CIRCULATIONAHA.124.072849.

    PMID: 39906986
  20. 20

    Management of 2-Stage Breast Reconstruction in Ehlers-Danlos Syndrome: A Case Report.

    Timothy N, Patrick M, Dayicioglu D

    Eplasty 2024; (24()):e5.

    PMID: 38476521
  21. 21

    Natural history of gastrointestinal manifestations in vascular Ehlers-Danlos syndrome: A 17-year retrospective review.

    Frank M, Adham S, Zinzindohoué F, Jeunemaitre X

    Journal of gastroenterology and hepatology 2019; (34(5)):857-863 doi:10.1111/jgh.14522.

    PMID: 30357907
  22. 22

    Vascular Injury After Scoliosis Correction in Ehlers-Danlos Syndrome: Proceed With Caution.

    Prabhakar G, Gonuguntla RK, Momtaz D, et al.

    Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews 2023; (7(8)) doi:10.5435/JAAOSGlobal-D-23-00061.

    PMID: 37581952
  23. 23

    Peripartum considerations and challenges in the management of type IV Ehlers-Danlos syndrome.

    Makam H, Siddiqui F, Patwardhan A, Darbar A

    BMJ case reports 2021; (14(7)) doi:10.1136/bcr-2020-239916.

    PMID: 34330720
  24. 24

    Endovascular Management of Vascular Complications in Ehlers-Danlos Syndrome Type IV.

    Alqahtani M, Claudinot A, Gaudry M, et al.

    Journal of clinical medicine 2022; (11(21)) doi:10.3390/jcm11216344.

    PMID: 36362573

This page provides general management strategies for Ehlers-Danlos Syndrome. Always consult your specialized healthcare team before starting new physical therapy regimens or medications.

Stay up to date

Get notified when new research about Ehlers Danlos Syndrome (EDS) is published.

No spam. Unsubscribe anytime.